Atlas Trials

TC Biopharm

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch TC Biopharm

RecordFirmDate
ACHIEVE2 - Safety and Preliminary Efficacy of Intravenous TCB008 in Patients With Relapse or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)/AML (NCT06463327)TC Biopharm2025-01-01
ACHIEVE - Efficacy and Effectiveness of Adoptive Cellular tHerapy wIth Ex-Vivo Expanded Allogeneic γδ T-lymphocytes (TCB008) for Patients With Refractory or Relapsed Acute Myeloid Leukaemia (AML) (NCT05358808)TC Biopharm2022-08-15
A Phase II Safety and Tolerability Study of TCB008 in Patients With COVID-19 (NCT04834128)TC Biopharm2021-12-13
Ex-vivo Expanded γδ T-lymphocytes (OmnImmune®) in Patients With Acute Myeloid Leukaemia (AML) (NCT03790072)TC Biopharm2018-11-27

Track TC Biopharm automatically

Every clearance here is in the API, with alerts when new ones post.